On May 29, 2025, Nihin Media Inc. (headquartered in Shibuya, Tokyo) is pleased to announce the release of MedGen Japan v2.0—a major upgrade that significantly enhances the platform’s performance across multiple dimensions, including drug name recognition accuracy, response speed, and evidence coverage.
Additionally, we are excited to share that as of May, we have launched a joint development project with Dr. Masashi Misawa of Showa University Yokohama Northern Hospital to further improve the real-world clinical experience of MedGen Japan.